8-KMaterial AgreementsFinancial EventsExhibits & Filings

HCA Healthcare, Inc. 8-K Report, Material Agreement (Mar 18, 2016)

Filed March 18, 2016For Securities:HCA

Summary

This 8-K filing from HCA Holdings, Inc. on March 18, 2016, primarily concerns a material amendment to its existing senior secured term loan credit facility. The company, through its wholly-owned subsidiary HCA Inc., entered into a joinder agreement to replace its Tranche B-5 Term Loan Facility with a new $1.50 billion Tranche B-6 Term Loan Facility. This refinancing extends the maturity date of this specific debt tranche from March 31, 2017, to March 18, 2023. While the new facility is on substantially the same terms, key changes include updated interest rates (LIBOR plus a 3.25% margin or base rate plus a 2.25% margin) and a modified amortization schedule requiring 0.25% of the principal amount to be paid quarterly. Investors should note the extended maturity provides greater financial flexibility, and the new terms offer insights into HCA's current borrowing costs and debt management strategy.

Key Highlights

  • 1HCA Holdings, Inc. refinanced its senior secured term B-5 loan facility with a new $1.50 billion senior secured term B-6 loan facility.
  • 2The new Tranche B-6 Term Loan Facility matures on March 18, 2023, extending the maturity from the previous Tranche B-5's March 31, 2017 date.
  • 3The new facility has updated interest rates: LIBOR plus a 3.25% margin, or a base rate plus a 2.25% margin.
  • 4Amortization payments on the new facility are set at 0.25% of the principal amount per fiscal quarter.
  • 5A 1.00% prepayment premium will apply to voluntary prepayments made within twelve months of the joinder agreement's effective date in connection with a repricing transaction.
  • 6The transaction was executed by HCA Inc., a direct, wholly owned subsidiary of HCA Holdings, Inc.
  • 7The filing incorporates by reference the Joinder Agreement No. 2 as Exhibit 4.1.

Frequently Asked Questions